FDA label 79772a8b-2c27-10af-e053-2a91aa0a3a82

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

SPL set ID
cfdfd696-3185-48bb-ac50-f4a2ed512991
SPL ID
79772a8b-2c27-10af-e053-2a91aa0a3a82
Version
8
Effective date
2018-10-30
Source export date
2026-11-13
Source partition
13
Source file
https://download.open.fda.gov/drug/label/drug-label-0013-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-11-13/59f616a891fdb32b85469f3498f080490e31c92c33c42932fcf32980bd661882/drug-label-0013-of-0014.json.zip
Source manifest SHA-256
8f2b6d063d44586cf97cedcdf1bdf9e261cc88632cc6855424b801bb206208d7
Import run
20261116T150851Z
Imported at
2026-11-16 18:00:34

Boxed warning cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Boxed warning sections page 1 of 1 · 1 matching rows.

boxed warning

WARNING: SUICIDALITY AND ANTIDEPRESSANT DRUGS Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults in short-term studies of Major Depressive Disorder (MDD) and other psychiatric disorders. Anyone considering the use of fluoxetine or any other antidepressant in a child, adolescent, or young adult must balance this risk with the clinical need. Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond age 24; there was a reduction in risk with antidepressants compared to placebo in adults aged 65 and older. Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide. Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior. Families and caregivers should be advised of the need for close observation and communication with the prescriber. Fluoxetine is approved for use in pediatric patients with MDD and Obsessive Compulsive Disorder (OCD) [see Warnings and Precautions (5.1) and Use in Specific Populations (8.4)] . When using fluoxetineand olanzapine in combination, also refer to Boxed Warning section of the package insert for olanzapine and fluoxetine hydrochloride capsules. WARNING: SUICIDALITY AND ANTIDEPRESSANT DRUGS See full prescribing information for complete boxed warning. Increased risk of suicidal thinking and behavior in children, adolescents, and young adults taking antidepressants for Major Depressive Disorder (MDD) and other psychiatric disorders (5.1). When using fluoxetine and olanzapine in combination, also refer to Boxed Warning section of the package insert for olanzapine and fluoxetine hydrochloride capsules.

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 2 of 5 · 17 matching rows.

warnings and cautions

5.4 Screening Patients for Bipolar Disorder and Monitoring for Mania/Hypomania A major depressive episode may be the initial presentation of Bipolar Disorder. It is generally believed (though not established in controlled trials) that treating such an episode with an antidepressant alone may increase the likelihood of precipitation of a mixed/manic episode in patients at risk for Bipolar Disorder. Whether any of the symptoms described for clinical worsening and suicide risk represent such a conversion is unknown. However, prior to initiating treatment with an antidepressant, patients with depressive symptoms should be adequately screened to determine if they are at risk for Bipolar Disorder; such screening should include a detailed psychiatric history, including a family history of suicide, Bipolar Disorder, and depression. It should be noted that fluoxetine and olanzapine in combination is approved for the acute treatment of depressive episodes associated with Bipolar I Disorder [see Warnings and Precautions section of the package insert for olanzapine and fluoxetine hydrochloride capsules ] . Fluoxetine monotherapy is not indicated for the treatment of depressive episodes associated with Bipolar I Disorder. In US placebo-controlled clinical trials for Major Depressive Disorder, mania/hypomania was reported in 0.1% of patients treated with fluoxetine and 0.1% of patients treated with placebo. Activation of mania/hypomania has also been reported in a small proportion of patients with Major Affective Disorder treated with other marketed drugs effective in the treatment of Major Depressive Disorder [see Use in Specific Populations (8.4) ] . In US placebo-controlled clinical trials for OCD, mania/hypomania was reported in 0.8% of patients treated with fluoxetine and no patients treated with placebo. No patients reported mania/hypomania in US placebo-controlled clinical trials for bulimia. In US fluoxetine clinical trials, 0.7% of 10,782 patients reported mania/hypomania [see Use in Specific Populations (8.4) ] .

warnings and cautions

5.5 Seizures In US placebo-controlled clinical trials for Major Depressive Disorder, convulsions (or reactions described as possibly having been seizures) were reported in 0.1% of patients treated with fluoxetine and 0.2% of patients treated with placebo. No patients reported convulsions in US placebo-controlled clinical trials for either OCD or bulimia. In US fluoxetine clinical trials, 0.2% of 10,782 patients reported convulsions. The percentage appears to be similar to that associated with other marketed drugs effective in the treatment of Major Depressive Disorder. Fluoxetine should be introduced with care in patients with a history of seizures.

warnings and cautions

5.6 Altered Appetite and Weight Significant weight loss, especially in underweight depressed or bulimic patients, may be an undesirable result of treatment with fluoxetine. In US placebo-controlled clinical trials for Major Depressive Disorder, 11% of patients treated with fluoxetine and 2% of patients treated with placebo reported anorexia (decreased appetite). Weight loss was reported in 1.4% of patients treated with fluoxetine and in 0.5% of patients treated with placebo. However, only rarely have patients discontinued treatment with fluoxetine because of anorexia or weight loss [see Use in Specific Populations (8.4) ] . In US placebo-controlled clinical trials for OCD, 17% of patients treated with fluoxetine and 10% of patients treated with placebo reported anorexia (decreased appetite). One patient discontinued treatment with fluoxetine because of anorexia [see Use in Specific Populations (8.4) ] . In US placebo-controlled clinical trials for Bulimia Nervosa, 8% of patients treated with fluoxetine 60 mg and 4% of patients treated with placebo reported anorexia (decreased appetite). Patients treated with fluoxetine 60 mg on average lost 0.45 kg compared with a gain of 0.16 kg by patients treated with placebo in the 16-week double-blind trial. Weight change should be monitored during therapy.

warnings and cautions

5.7 Abnormal Bleeding SNRIs and SSRIs, including fluoxetine, may increase the risk of bleeding reactions. Concomitant use of aspirin, nonsteroidal anti-inflammatory drugs, warfarin, and other anti-coagulants may add to this risk. Case reports and epidemiological studies (case-control and cohort design) have demonstrated an association between use of drugs that interfere with serotonin reuptake and the occurrence of gastrointestinal bleeding. Bleeding reactions related to SNRIs and SSRIs use have ranged from ecchymoses, hematomas, epistaxis, and petechiae to life-threatening hemorrhages. Patients should be cautioned about the risk of bleeding associated with the concomitant use of fluoxetine and NSAIDs, aspirin, warfarin, or other drugs that affect coagulation [see Drug Interactions (7.4) ] .

Adverse reactions cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Adverse reactions sections page 1 of 2 · 8 matching rows.

adverse reactions

6 ADVERSE REACTIONS When using fluoxetine and olanzapine in combination, also refer to the Adverse Reactions section of the package insert for olanzapine and fluoxetine hydrochloride capsules. Most common adverse reactions (≥ 5% and at least twice that for placebo) associated with: Major Depressive Disorder, Obsessive Compulsive Disorder, Bulimia, and Panic Disorder: abnormal dreams, abnormal ejaculation, anorexia, anxiety, asthenia, diarrhea, dry mouth, dyspepsia, flu syndrome, impotence, insomnia, libido decreased, nausea, nervousness, pharyngitis, rash, sinusitis, somnolence, sweating, tremor, vasodilatation, and yawn (6.1) Fluoxetine and olanzapine in combination – Also refer to the Adverse Reactions section of the package insert for olanzapine and fluoxetine hydrochloride capsules (6) To report SUSPECTED ADVERSE REACTIONS, contact Ranbaxy Pharmaceuticals Inc. at 1-888-Ranbaxy (726-2299) or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch 6.1 Clinical Trials Experience Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect or predict the rates observed in practice. Multiple doses of fluoxetine have been administered to 10,782 patients with various diagnoses in US clinical trials. In addition, there have been 425 patients administered fluoxetine in panic clinical trials. Adverse reactions were recorded by clinical investigators using descriptive terminology of their own choosing. Consequently, it is not possible to provide a meaningful estimate of the proportion of individuals experiencing adverse reactions without first grouping similar types of reactions into a limited (i.e., reduced) number of standardized reaction categories. In the tables and tabulations that follow, COSTART Dictionary terminology has been used to classify reported adverse reactions. The stated frequencies represent the proportion of individuals who experienced, at least once, a treatment-emergent adverse reaction of the type listed. A reaction was considered treatment-emergent if it occurred for the first time or worsened while receiving therapy following baseline evaluation. It is important to emphasize that reactions reported during therapy were not necessarily caused by it. The prescriber should be aware that the figures in the tables and tabulations cannot be used to predict the incidence of side effects in the course of usual medical practice where patient characteristics and other factors differ from those that prevailed in the clinical trials. Similarly, the cited frequencies cannot be compared with figures obtained from other clinical investigations involving different treatments, uses, and investigators. The cited figures, however, do provide the prescribing physician with some basis for estimating the relative contribution of drug and nondrug factors to the side effect incidence rate in the population studied. Incidence in Major Depressive Disorder, OCD, bulimia, and Panic Disorder placebo-controlled clinical trials (excluding data from extensions of trials) — Table 3 enumerates the most common treatment-emergent adverse reactions associated with the use of fluoxetine (incidence of at least 5% for fluoxetine and at least twice that for placebo within at least 1 of the indications) for the treatment of Major Depressive Disorder, OCD, and bulimia in US controlled clinical trials and Panic Disorder in US plus non-US controlled trials. Table 5 enumerates treatment-emergent adverse reactions that occurred in 2% or more patients treated with fluoxetine and with incidence greater than placebo who participated in US Major Depressive Disorder, OCD, and bulimia controlled clinical trials and US plus non-US Panic Disorder controlled clinical trials. Table 4 provides combined data for the pool of studies that are provided separately by indication in Table 3. Table 3: Most Common Treatment-Emergent Adverse Reactions: Incidence in Major Depressive Disorder, OCD, Bulimia, and Panic Disorder Placebo-Controlled Clinical Trials 1,2 Percentage of Patients Reporting Event Major DepressiveDisorder OCD Bulimia Panic Disorder Body System/Adverse Reaction Fluoxetine (N = 1728) Placebo(N = 975) Fluoxetine(N = 266) Placebo(N = 89) Fluoxetine(N = 450) Placebo(N = 267) Fluoxetine(N = 425) Placebo(N = 342) Body as a Whole Asthenia 9 5 15 11 21 9 7 7 Flu syndrome 3 4 10 7 8 3 5 5 Cardiovascular System Vasodilatation 3 2 5 -- 2 1 1 -- Digestive System Nausea 21 9 26 13 29 11 12 7 Diarrhea 12 8 18 13 8 6 9 4 Anorexia 11 2 17 10 8 4 4 1 Dry mouth 10 7 12 3 9 6 4 4 Dyspepsia 7 5 10 4 10 6 6 2 Nervous System Insomnia 16 9 28 22 33 13 10 7 Anxiety 12 7 14 7 15 9 6 2 Nervousness 14 9 14 15 11 5 8 6 Somnolence 13 6 17 7 13 5 5 2 Tremor 10 3 9 1 13 1 3 1 Libido decreased 3 -- 11 2 5 1 1 2 Abnormal dreams 1 1 5 2 5 3 1 1 Respiratory System Pharyngitis 3 3 11 9 10 5 3 3 Sinusitis 1 4 5 2 6 4 2 3 Yawn -- -- 7 -- 11 -- 1 -- Skin and Appendages Sweating 8 3 7 -- 8 3 2 2 Rash 4 3 6 3 4 4 2 2 Urogenital System Impotence 3 2 -- -- -- 7 -- 1 -- Abnormal ejaculation 3 -- -- 7 -- 7 -- 2 1 1 Incidence less than 1%. 2 Includes US data for Major Depressive Disorder, OCD, Bulimia, and Panic Disorder clinical trials, plus non-US data for Panic Disorder clinical trials. 3 Denominator used was for males only (N = 690 fluoxetine Major Depressive Disorder; N = 410 placebo Major Depressive Disorder; N = 116 fluoxetine OCD; N = 43 placebo OCD; N = 14 fluoxetine bulimia; N = 1 placebo bulimia; N = 162 fluoxetine panic; N = 121 placebo panic). Table 4: Treatment-Emergent Adverse Reactions: Incidence in Major Depressive Disorder, OCD, Bulimia, and Panic Disorder Placebo-Controlled Clinical Trials 1,2 Percentage of Patients Reporting Event Major Depressive Disorder, OCD, Bulimia, and Panic Disorder Combined Body System/Adverse Reaction Fluoxetine(N = 2869) Placebo(N = 1673) Body as a Whole Headache 21 19 Asthenia 11 6 Flu syndrome 5 4 Fever 2 1 Cardiovascular System Vasodilatation 2 1 Digestive System Nausea 22 9 Diarrhea 11 7 Anorexia 10 3 Dry mouth 9 6 Dyspepsia 8 4 Constipation 5 4 Flatulence 3 2 Vomiting 3 2 Metabolic and Nutritional Disorders Weight loss 2 1 Nervous System Insomnia 19 10 Nervousness 13 8 Anxiety 12 6 Somnolence 12 5 Dizziness 9 6 Tremor 9 2 Libido decreased 4 1 Thinking abnormal 2 1 Respiratory System Yawn 3 -- Skin and Appendages Sweating 7 3 Rash 4 3 Pruritus 3 2 Special Senses Abnormal vision 2 1 1 Incidence less than 1%. 2 Includes US data for Major Depressive Disorder, OCD, bulimia, and Panic Disorder clinical trials, plus non-US data for Panic Disorder clinical trials. Associated with discontinuation in Major Depressive Disorder, OCD, bulimia, and Panic Disorder placebo-controlled clinical trials (excluding data from extensions of trials) — Table 5 lists the adverse reactions associated with discontinuation of fluoxetine treatment (incidence at least twice that for placebo and at least 1% for fluoxetine in clinical trials collecting only a primary reaction associated with discontinuation) in Major Depressive Disorder, OCD, bulimia, and Panic Disorder clinical trials, plus non-US Panic Disorder clinical trials. Table 5: Most Common Adverse Reactions Associated with Discontinuation in Major Depressive Disorder, OCD, Bulimia, and Panic Disorder Placebo-Controlled Clinical Trials 1 Major DepressiveDisorder, OCD, Bulimia, and Panic DisorderCombined (N = 1533) MajorDepressive Disorder (N = 392) OCD (N = 266) Bulimia (N = 450) Panic Disorder (N = 425) Anxiety (1%) -- Anxiety (2%) -- Anxiety (2%) -- -- -- Insomnia (2%) -- -- Nervousness (1%) -- -- Nervousness (1%) -- -- Rash (1%) -- -- 1 Includes US Major Depressive Disorder, OCD, bulimia, and Panic Disorder clinical trials, plus non-US Panic Disorder clinical trials. Other adverse reactions in pediatric patients (children and adolescents) — Treatment-emergent adverse reactions were collected in 322 pediatric patients (180 fluoxetine-treated, 142 placebo-treated). The overall profile of adverse reactions was generally similar to that seen in adult studies, as shown in Tables 4 and 5. However, the following adverse reactions (excluding those which appear in the body or footnotes of Tables 4 and 5 and those for which the COSTART terms were uninformative or misleading) were reported at an incidence of at least 2% for fluoxetine and greater than placebo: thirst, hyperkinesia, agitation, personality disorder, epistaxis, urinary frequency, and menorrhagia.

adverse reactions

6.1 Clinical Trials Experience Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect or predict the rates observed in practice. Multiple doses of fluoxetine have been administered to 10,782 patients with various diagnoses in US clinical trials. In addition, there have been 425 patients administered fluoxetine in panic clinical trials. Adverse reactions were recorded by clinical investigators using descriptive terminology of their own choosing. Consequently, it is not possible to provide a meaningful estimate of the proportion of individuals experiencing adverse reactions without first grouping similar types of reactions into a limited (i.e., reduced) number of standardized reaction categories. In the tables and tabulations that follow, COSTART Dictionary terminology has been used to classify reported adverse reactions. The stated frequencies represent the proportion of individuals who experienced, at least once, a treatment-emergent adverse reaction of the type listed. A reaction was considered treatment-emergent if it occurred for the first time or worsened while receiving therapy following baseline evaluation. It is important to emphasize that reactions reported during therapy were not necessarily caused by it. The prescriber should be aware that the figures in the tables and tabulations cannot be used to predict the incidence of side effects in the course of usual medical practice where patient characteristics and other factors differ from those that prevailed in the clinical trials. Similarly, the cited frequencies cannot be compared with figures obtained from other clinical investigations involving different treatments, uses, and investigators. The cited figures, however, do provide the prescribing physician with some basis for estimating the relative contribution of drug and nondrug factors to the side effect incidence rate in the population studied. Incidence in Major Depressive Disorder, OCD, bulimia, and Panic Disorder placebo-controlled clinical trials (excluding data from extensions of trials) — Table 3 enumerates the most common treatment-emergent adverse reactions associated with the use of fluoxetine (incidence of at least 5% for fluoxetine and at least twice that for placebo within at least 1 of the indications) for the treatment of Major Depressive Disorder, OCD, and bulimia in US controlled clinical trials and Panic Disorder in US plus non-US controlled trials. Table 5 enumerates treatment-emergent adverse reactions that occurred in 2% or more patients treated with fluoxetine and with incidence greater than placebo who participated in US Major Depressive Disorder, OCD, and bulimia controlled clinical trials and US plus non-US Panic Disorder controlled clinical trials. Table 4 provides combined data for the pool of studies that are provided separately by indication in Table 3. Table 3: Most Common Treatment-Emergent Adverse Reactions: Incidence in Major Depressive Disorder, OCD, Bulimia, and Panic Disorder Placebo-Controlled Clinical Trials 1,2 Percentage of Patients Reporting Event Major DepressiveDisorder OCD Bulimia Panic Disorder Body System/Adverse Reaction Fluoxetine (N = 1728) Placebo(N = 975) Fluoxetine(N = 266) Placebo(N = 89) Fluoxetine(N = 450) Placebo(N = 267) Fluoxetine(N = 425) Placebo(N = 342) Body as a Whole Asthenia 9 5 15 11 21 9 7 7 Flu syndrome 3 4 10 7 8 3 5 5 Cardiovascular System Vasodilatation 3 2 5 -- 2 1 1 -- Digestive System Nausea 21 9 26 13 29 11 12 7 Diarrhea 12 8 18 13 8 6 9 4 Anorexia 11 2 17 10 8 4 4 1 Dry mouth 10 7 12 3 9 6 4 4 Dyspepsia 7 5 10 4 10 6 6 2 Nervous System Insomnia 16 9 28 22 33 13 10 7 Anxiety 12 7 14 7 15 9 6 2 Nervousness 14 9 14 15 11 5 8 6 Somnolence 13 6 17 7 13 5 5 2 Tremor 10 3 9 1 13 1 3 1 Libido decreased 3 -- 11 2 5 1 1 2 Abnormal dreams 1 1 5 2 5 3 1 1 Respiratory System Pharyngitis 3 3 11 9 10 5 3 3 Sinusitis 1 4 5 2 6 4 2 3 Yawn -- -- 7 -- 11 -- 1 -- Skin and Appendages Sweating 8 3 7 -- 8 3 2 2 Rash 4 3 6 3 4 4 2 2 Urogenital System Impotence 3 2 -- -- -- 7 -- 1 -- Abnormal ejaculation 3 -- -- 7 -- 7 -- 2 1 1 Incidence less than 1%. 2 Includes US data for Major Depressive Disorder, OCD, Bulimia, and Panic Disorder clinical trials, plus non-US data for Panic Disorder clinical trials. 3 Denominator used was for males only (N = 690 fluoxetine Major Depressive Disorder; N = 410 placebo Major Depressive Disorder; N = 116 fluoxetine OCD; N = 43 placebo OCD; N = 14 fluoxetine bulimia; N = 1 placebo bulimia; N = 162 fluoxetine panic; N = 121 placebo panic). Table 4: Treatment-Emergent Adverse Reactions: Incidence in Major Depressive Disorder, OCD, Bulimia, and Panic Disorder Placebo-Controlled Clinical Trials 1,2 Percentage of Patients Reporting Event Major Depressive Disorder, OCD, Bulimia, and Panic Disorder Combined Body System/Adverse Reaction Fluoxetine(N = 2869) Placebo(N = 1673) Body as a Whole Headache 21 19 Asthenia 11 6 Flu syndrome 5 4 Fever 2 1 Cardiovascular System Vasodilatation 2 1 Digestive System Nausea 22 9 Diarrhea 11 7 Anorexia 10 3 Dry mouth 9 6 Dyspepsia 8 4 Constipation 5 4 Flatulence 3 2 Vomiting 3 2 Metabolic and Nutritional Disorders Weight loss 2 1 Nervous System Insomnia 19 10 Nervousness 13 8 Anxiety 12 6 Somnolence 12 5 Dizziness 9 6 Tremor 9 2 Libido decreased 4 1 Thinking abnormal 2 1 Respiratory System Yawn 3 -- Skin and Appendages Sweating 7 3 Rash 4 3 Pruritus 3 2 Special Senses Abnormal vision 2 1 1 Incidence less than 1%. 2 Includes US data for Major Depressive Disorder, OCD, bulimia, and Panic Disorder clinical trials, plus non-US data for Panic Disorder clinical trials. Associated with discontinuation in Major Depressive Disorder, OCD, bulimia, and Panic Disorder placebo-controlled clinical trials (excluding data from extensions of trials) — Table 5 lists the adverse reactions associated with discontinuation of fluoxetine treatment (incidence at least twice that for placebo and at least 1% for fluoxetine in clinical trials collecting only a primary reaction associated with discontinuation) in Major Depressive Disorder, OCD, bulimia, and Panic Disorder clinical trials, plus non-US Panic Disorder clinical trials. Table 5: Most Common Adverse Reactions Associated with Discontinuation in Major Depressive Disorder, OCD, Bulimia, and Panic Disorder Placebo-Controlled Clinical Trials 1 Major DepressiveDisorder, OCD, Bulimia, and Panic DisorderCombined (N = 1533) MajorDepressive Disorder (N = 392) OCD (N = 266) Bulimia (N = 450) Panic Disorder (N = 425) Anxiety (1%) -- Anxiety (2%) -- Anxiety (2%) -- -- -- Insomnia (2%) -- -- Nervousness (1%) -- -- Nervousness (1%) -- -- Rash (1%) -- -- 1 Includes US Major Depressive Disorder, OCD, bulimia, and Panic Disorder clinical trials, plus non-US Panic Disorder clinical trials. Other adverse reactions in pediatric patients (children and adolescents) — Treatment-emergent adverse reactions were collected in 322 pediatric patients (180 fluoxetine-treated, 142 placebo-treated). The overall profile of adverse reactions was generally similar to that seen in adult studies, as shown in Tables 4 and 5. However, the following adverse reactions (excluding those which appear in the body or footnotes of Tables 4 and 5 and those for which the COSTART terms were uninformative or misleading) were reported at an incidence of at least 2% for fluoxetine and greater than placebo: thirst, hyperkinesia, agitation, personality disorder, epistaxis, urinary frequency, and menorrhagia.

adverse reactions table

<table ID="_Refinv-dee9a2b3-d58e-496f-8582-e35a23cf" width="100%"> <caption>Table 3: Most Common Treatment-Emergent Adverse Reactions: Incidence in Major Depressive Disorder, OCD, Bulimia, and Panic Disorder Placebo-Controlled Clinical Trials <sup>1,2</sup> </caption> <col width="14%"/> <col width="10%"/> <col width="10%"/> <col width="12%"/> <col width="10%"/> <col width="12%"/> <col width="10%"/> <col width="12%"/> <col width="10%"/> <tbody> <tr> <td styleCode="Botrule Lrule Toprule " valign="top"/> <td align="center" colspan="8" styleCode="Rrule Botrule Toprule " valign="top"> <paragraph> <content styleCode="bold">Percentage of Patients Reporting Event</content> </paragraph> </td> </tr> <tr> <td styleCode="Lrule Botrule " valign="top"/> <td align="center" colspan="2" styleCode="Botrule " valign="top"> <paragraph> <content styleCode="bold">Major DepressiveDisorder</content> </paragraph> </td> <td align="center" colspan="2" styleCode="Botrule " valign="top"> <paragraph> <content styleCode="bold">OCD</content> </paragraph> </td> <td align="center" colspan="2" styleCode="Botrule " valign="top"> <paragraph> <content styleCode="bold">Bulimia</content> </paragraph> </td> <td align="center" colspan="2" styleCode="Rrule Botrule " valign="top"> <paragraph> <content styleCode="bold">Panic Disorder</content> </paragraph> </td> </tr> <tr> <td rowspan="2" styleCode="Lrule Botrule " valign="top"> <paragraph> <content styleCode="bold">Body System/Adverse Reaction</content> </paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> <content styleCode="bold">Fluoxetine (N = 1728)</content> </paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> <content styleCode="bold">Placebo(N = 975)</content> </paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> <content styleCode="bold">Fluoxetine(N = 266)</content> </paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> <content styleCode="bold">Placebo(N = 89)</content> </paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> <content styleCode="bold">Fluoxetine(N = 450)</content> </paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> <content styleCode="bold">Placebo(N = 267)</content> </paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> <content styleCode="bold">Fluoxetine(N = 425)</content> </paragraph> </td> <td align="center" styleCode="Rrule Botrule " valign="top"> <paragraph> <content styleCode="bold">Placebo(N = 342)</content> </paragraph> </td> </tr> <tr> <td styleCode="Lrule Botrule " valign="top"/> <td styleCode="Botrule " valign="top"/> <td styleCode="Botrule " valign="top"/> <td styleCode="Botrule " valign="top"/> <td styleCode="Botrule " valign="top"/> <td styleCode="Botrule " valign="top"/> <td styleCode="Botrule " valign="top"/> <td styleCode="Rrule Botrule " valign="top"/> </tr> <tr> <td styleCode="Lrule Botrule " valign="top"> <paragraph> <content styleCode="bold">Body as a Whole</content> </paragraph> </td> <td styleCode="Botrule " valign="top"/> <td styleCode="Botrule " valign="top"/> <td styleCode="Botrule " valign="top"/> <td styleCode="Botrule " valign="top"/> <td styleCode="Botrule " valign="top"/> <td styleCode="Botrule " valign="top"/> <td styleCode="Botrule " valign="top"/> <td styleCode="Rrule Botrule " valign="top"/> </tr> <tr> <td styleCode="Lrule Botrule " valign="top"> <paragraph> Asthenia</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 9</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 5</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 15</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 11</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 21</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 9</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 7</paragraph> </td> <td align="center" styleCode="Rrule Botrule " valign="top"> <paragraph> 7</paragraph> </td> </tr> <tr> <td styleCode="Lrule Botrule " valign="top"> <paragraph> Flu syndrome</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 3</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 4</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 10</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 7</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 8</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 3</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 5</paragraph> </td> <td align="center" styleCode="Rrule Botrule " valign="top"> <paragraph> 5</paragraph> </td> </tr> <tr> <td styleCode="Lrule Botrule " valign="top"> <paragraph> <content styleCode="bold">Cardiovascular System</content> </paragraph> </td> <td styleCode="Botrule " valign="top"/> <td styleCode="Botrule " valign="top"/> <td styleCode="Botrule " valign="top"/> <td styleCode="Botrule " valign="top"/> <td styleCode="Botrule " valign="top"/> <td styleCode="Botrule " valign="top"/> <td styleCode="Botrule " valign="top"/> <td styleCode="Rrule Botrule " valign="top"/> </tr> <tr> <td styleCode="Lrule Botrule " valign="top"> <paragraph> Vasodilatation</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 3</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 2</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 5</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> --</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 2</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 1</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 1</paragraph> </td> <td align="center" styleCode="Rrule Botrule " valign="top"> <paragraph> --</paragraph> </td> </tr> <tr> <td styleCode="Lrule Botrule " valign="top"> <paragraph> <content styleCode="bold">Digestive System</content> </paragraph> </td> <td styleCode="Botrule " valign="top"/> <td styleCode="Botrule " valign="top"/> <td styleCode="Botrule " valign="top"/> <td styleCode="Botrule " valign="top"/> <td styleCode="Botrule " valign="top"/> <td styleCode="Botrule " valign="top"/> <td styleCode="Botrule " valign="top"/> <td styleCode="Rrule Botrule " valign="top"/> </tr> <tr> <td styleCode="Lrule Botrule " valign="top"> <paragraph> Nausea</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 21</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 9</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 26</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 13</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 29</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 11</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 12</paragraph> </td> <td align="center" styleCode="Rrule Botrule " valign="top"> <paragraph> 7</paragraph> </td> </tr> <tr> <td styleCode="Lrule Botrule " valign="top"> <paragraph> Diarrhea</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 12</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 8</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 18</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 13</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 8</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 6</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 9</paragraph> </td> <td align="center" styleCode="Rrule Botrule " valign="top"> <paragraph> 4</paragraph> </td> </tr> <tr> <td styleCode="Lrule Botrule " valign="top"> <paragraph> Anorexia</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 11</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 2</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 17</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 10</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 8</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 4</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 4</paragraph> </td> <td align="center" styleCode="Rrule Botrule " valign="top"> <paragraph> 1</paragraph> </td> </tr> <tr> <td styleCode="Lrule Botrule " valign="top"> <paragraph> Dry mouth</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 10</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 7</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 12</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 3</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 9</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 6</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 4</paragraph> </td> <td align="center" styleCode="Rrule Botrule " valign="top"> <paragraph> 4</paragraph> </td> </tr> <tr> <td styleCode="Lrule Botrule " valign="top"> <paragraph> Dyspepsia</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 7</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 5</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 10</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 4</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 10</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 6</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 6</paragraph> </td> <td align="center" styleCode="Rrule Botrule " valign="top"> <paragraph> 2</paragraph> </td> </tr> <tr> <td styleCode="Lrule Botrule " valign="top"> <paragraph> <content styleCode="bold">Nervous System</content> </paragraph> </td> <td styleCode="Botrule " valign="top"/> <td styleCode="Botrule " valign="top"/> <td styleCode="Botrule " valign="top"/> <td styleCode="Botrule " valign="top"/> <td styleCode="Botrule " valign="top"/> <td styleCode="Botrule " valign="top"/> <td styleCode="Botrule " valign="top"/> <td styleCode="Rrule Botrule " valign="top"/> </tr> <tr> <td styleCode="Lrule Botrule " valign="top"> <paragraph> Insomnia</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 16</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 9</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 28</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 22</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 33</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 13</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 10</paragraph> </td> <td align="center" styleCode="Rrule Botrule " valign="top"> <paragraph> 7</paragraph> </td> </tr> <tr> <td styleCode="Lrule Botrule " valign="top"> <paragraph> Anxiety</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 12</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 7</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 14</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 7</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 15</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 9</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 6</paragraph> </td> <td align="center" styleCode="Rrule Botrule " valign="top"> <paragraph> 2</paragraph> </td> </tr> <tr> <td styleCode="Lrule Botrule " valign="top"> <paragraph> Nervousness</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 14</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 9</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 14</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 15</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 11</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 5</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 8</paragraph> </td> <td align="center" styleCode="Rrule Botrule " valign="top"> <paragraph> 6</paragraph> </td> </tr> <tr> <td styleCode="Lrule Botrule " valign="top"> <paragraph> Somnolence</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 13</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 6</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 17</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 7</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 13</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 5</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 5</paragraph> </td> <td align="center" styleCode="Rrule Botrule " valign="top"> <paragraph> 2</paragraph> </td> </tr> <tr> <td styleCode="Lrule Botrule " valign="top"> <paragraph> Tremor</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 10</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 3</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 9</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 1</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 13</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 1</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 3</paragraph> </td> <td align="center" styleCode="Rrule Botrule " valign="top"> <paragraph> 1</paragraph> </td> </tr> <tr> <td styleCode="Lrule Botrule " valign="top"> <paragraph> Libido decreased</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 3</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> --</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 11</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 2</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 5</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 1</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 1</paragraph> </td> <td align="center" styleCode="Rrule Botrule " valign="top"> <paragraph> 2</paragraph> </td> </tr> <tr> <td styleCode="Lrule Botrule " valign="top"> <paragraph> Abnormal dreams</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 1</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 1</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 5</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 2</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 5</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 3</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 1</paragraph> </td> <td align="center" styleCode="Rrule Botrule " valign="top"> <paragraph> 1</paragraph> </td> </tr> <tr> <td styleCode="Lrule Botrule " valign="top"> <paragraph> <content styleCode="bold">Respiratory System</content> </paragraph> </td> <td styleCode="Botrule " valign="top"/> <td styleCode="Botrule " valign="top"/> <td styleCode="Botrule " valign="top"/> <td styleCode="Botrule " valign="top"/> <td styleCode="Botrule " valign="top"/> <td styleCode="Botrule " valign="top"/> <td styleCode="Botrule " valign="top"/> <td styleCode="Rrule Botrule " valign="top"/> </tr> <tr> <td styleCode="Lrule Botrule " valign="top"> <paragraph> Pharyngitis</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 3</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 3</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 11</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 9</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 10</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 5</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 3</paragraph> </td> <td align="center" styleCode="Rrule Botrule " valign="top"> <paragraph> 3</paragraph> </td> </tr> <tr> <td styleCode="Lrule Botrule " valign="top"> <paragraph> Sinusitis</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 1</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 4</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 5</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 2</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 6</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 4</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 2</paragraph> </td> <td align="center" styleCode="Rrule Botrule " valign="top"> <paragraph> 3</paragraph> </td> </tr> <tr> <td styleCode="Lrule Botrule " valign="top"> <paragraph> Yawn</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> --</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> --</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 7</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> --</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 11</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> --</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 1</paragraph> </td> <td align="center" styleCode="Rrule Botrule " valign="top"> <paragraph> --</paragraph> </td> </tr> <tr> <td styleCode="Lrule Botrule " valign="top"> <paragraph> <content styleCode="bold">Skin and Appendages</content> </paragraph> </td> <td styleCode="Botrule " valign="top"/> <td styleCode="Botrule " valign="top"/> <td styleCode="Botrule " valign="top"/> <td styleCode="Botrule " valign="top"/> <td styleCode="Botrule " valign="top"/> <td styleCode="Botrule " valign="top"/> <td styleCode="Botrule " valign="top"/> <td styleCode="Rrule Botrule " valign="top"/> </tr> <tr> <td styleCode="Lrule Botrule " valign="top"> <paragraph> Sweating</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 8</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 3</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 7</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> --</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 8</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 3</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 2</paragraph> </td> <td align="center" styleCode="Rrule Botrule " valign="top"> <paragraph> 2</paragraph> </td> </tr> <tr> <td styleCode="Lrule Botrule " valign="top"> <paragraph> Rash</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 4</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 3</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 6</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 3</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 4</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 4</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 2</paragraph> </td> <td align="center" styleCode="Rrule Botrule " valign="top"> <paragraph> 2</paragraph> </td> </tr> <tr> <td styleCode="Lrule Botrule " valign="top"> <paragraph> <content styleCode="bold">Urogenital System</content> </paragraph> </td> <td styleCode="Botrule " valign="top"/> <td styleCode="Botrule " valign="top"/> <td styleCode="Botrule " valign="top"/> <td styleCode="Botrule " valign="top"/> <td styleCode="Botrule " valign="top"/> <td styleCode="Botrule " valign="top"/> <td styleCode="Botrule " valign="top"/> <td styleCode="Rrule Botrule " valign="top"/> </tr> <tr> <td styleCode="Lrule Botrule " valign="top"> <paragraph> Impotence <sup>3</sup> </paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 2</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> --</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> --</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> --</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 7</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> --</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 1</paragraph> </td> <td align="center" styleCode="Rrule Botrule " valign="top"> <paragraph> --</paragraph> </td> </tr> <tr> <td styleCode="Botrule Lrule " valign="top"> <paragraph> Abnormal ejaculation <sup>3</sup> </paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> --</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> --</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 7</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> --</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 7</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> --</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 2</paragraph> </td> <td align="center" styleCode="Rrule Botrule " valign="top"> <paragraph> 1</paragraph> </td> </tr> </tbody> </table>

adverse reactions table

<table ID="_Refinv-5f90b0ad-e0f0-4220-97e2-fb72603f" width="100%"> <caption>Table 4: Treatment-Emergent Adverse Reactions: Incidence in Major Depressive Disorder, OCD, Bulimia, and Panic Disorder Placebo-Controlled Clinical Trials <sup>1,2</sup> </caption> <col width="44%"/> <col width="32%"/> <col width="24%"/> <tbody> <tr> <td styleCode="Botrule Lrule Toprule " valign="top"/> <td align="center" colspan="2" styleCode="Rrule Botrule Toprule " valign="top"> <paragraph> <content styleCode="bold">Percentage of Patients Reporting Event</content> </paragraph> </td> </tr> <tr> <td styleCode="Lrule Botrule " valign="top"/> <td align="center" colspan="2" styleCode="Rrule Botrule " valign="top"> <paragraph> <content styleCode="bold">Major Depressive Disorder, OCD, Bulimia, and Panic Disorder Combined</content> </paragraph> </td> </tr> <tr> <td styleCode="Lrule Botrule " valign="top"> <paragraph> <content styleCode="bold">Body System/Adverse Reaction</content> </paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> <content styleCode="bold">Fluoxetine(N = 2869)</content> </paragraph> </td> <td align="center" styleCode="Rrule Botrule " valign="top"> <paragraph> <content styleCode="bold">Placebo(N = 1673)</content> </paragraph> </td> </tr> <tr> <td styleCode="Lrule Botrule " valign="top"> <paragraph> <content styleCode="bold">Body as a Whole</content> </paragraph> </td> <td styleCode="Botrule " valign="top"/> <td styleCode="Rrule Botrule " valign="top"/> </tr> <tr> <td styleCode="Lrule Botrule " valign="top"> <paragraph> Headache</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 21</paragraph> </td> <td align="center" styleCode="Rrule Botrule " valign="top"> <paragraph> 19</paragraph> </td> </tr> <tr> <td styleCode="Lrule Botrule " valign="top"> <paragraph> Asthenia</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 11</paragraph> </td> <td align="center" styleCode="Rrule Botrule " valign="top"> <paragraph> 6</paragraph> </td> </tr> <tr> <td styleCode="Lrule Botrule " valign="top"> <paragraph> Flu syndrome</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 5</paragraph> </td> <td align="center" styleCode="Rrule Botrule " valign="top"> <paragraph> 4</paragraph> </td> </tr> <tr> <td styleCode="Lrule Botrule " valign="top"> <paragraph> Fever</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 2</paragraph> </td> <td align="center" styleCode="Rrule Botrule " valign="top"> <paragraph> 1</paragraph> </td> </tr> <tr> <td styleCode="Lrule Botrule " valign="top"> <paragraph> <content styleCode="bold">Cardiovascular System</content> </paragraph> </td> <td styleCode="Botrule " valign="top"/> <td styleCode="Rrule Botrule " valign="top"/> </tr> <tr> <td styleCode="Lrule Botrule " valign="top"> <paragraph> Vasodilatation</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 2</paragraph> </td> <td align="center" styleCode="Rrule Botrule " valign="top"> <paragraph> 1</paragraph> </td> </tr> <tr> <td styleCode="Lrule Botrule " valign="top"> <paragraph> <content styleCode="bold">Digestive System</content> </paragraph> </td> <td styleCode="Botrule " valign="top"/> <td styleCode="Rrule Botrule " valign="top"/> </tr> <tr> <td styleCode="Lrule Botrule " valign="top"> <paragraph> Nausea</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 22</paragraph> </td> <td align="center" styleCode="Rrule Botrule " valign="top"> <paragraph> 9</paragraph> </td> </tr> <tr> <td styleCode="Lrule Botrule " valign="top"> <paragraph> Diarrhea</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 11</paragraph> </td> <td align="center" styleCode="Rrule Botrule " valign="top"> <paragraph> 7</paragraph> </td> </tr> <tr> <td styleCode="Lrule Botrule " valign="top"> <paragraph> Anorexia</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 10</paragraph> </td> <td align="center" styleCode="Rrule Botrule " valign="top"> <paragraph> 3</paragraph> </td> </tr> <tr> <td styleCode="Lrule Botrule " valign="top"> <paragraph> Dry mouth</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 9</paragraph> </td> <td align="center" styleCode="Rrule Botrule " valign="top"> <paragraph> 6</paragraph> </td> </tr> <tr> <td styleCode="Lrule Botrule " valign="top"> <paragraph> Dyspepsia</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 8</paragraph> </td> <td align="center" styleCode="Rrule Botrule " valign="top"> <paragraph> 4</paragraph> </td> </tr> <tr> <td styleCode="Lrule Botrule " valign="top"> <paragraph> Constipation</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 5</paragraph> </td> <td align="center" styleCode="Rrule Botrule " valign="top"> <paragraph> 4</paragraph> </td> </tr> <tr> <td styleCode="Lrule Botrule " valign="top"> <paragraph> Flatulence</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 3</paragraph> </td> <td align="center" styleCode="Rrule Botrule " valign="top"> <paragraph> 2</paragraph> </td> </tr> <tr> <td styleCode="Lrule Botrule " valign="top"> <paragraph> Vomiting</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 3</paragraph> </td> <td align="center" styleCode="Rrule Botrule " valign="top"> <paragraph> 2</paragraph> </td> </tr> <tr> <td styleCode="Lrule Botrule " valign="top"> <paragraph> <content styleCode="bold">Metabolic and Nutritional Disorders</content> </paragraph> </td> <td styleCode="Botrule " valign="top"/> <td styleCode="Rrule Botrule " valign="top"/> </tr> <tr> <td styleCode="Lrule Botrule " valign="top"> <paragraph> Weight loss</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 2</paragraph> </td> <td align="center" styleCode="Rrule Botrule " valign="top"> <paragraph> 1</paragraph> </td> </tr> <tr> <td styleCode="Lrule Botrule " valign="top"> <paragraph> <content styleCode="bold">Nervous System</content> </paragraph> </td> <td styleCode="Botrule " valign="top"/> <td styleCode="Rrule Botrule " valign="top"/> </tr> <tr> <td styleCode="Lrule Botrule " valign="top"> <paragraph> Insomnia</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 19</paragraph> </td> <td align="center" styleCode="Rrule Botrule " valign="top"> <paragraph> 10</paragraph> </td> </tr> <tr> <td styleCode="Lrule Botrule " valign="top"> <paragraph> Nervousness</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 13</paragraph> </td> <td align="center" styleCode="Rrule Botrule " valign="top"> <paragraph> 8</paragraph> </td> </tr> <tr> <td styleCode="Lrule Botrule " valign="top"> <paragraph> Anxiety</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 12</paragraph> </td> <td align="center" styleCode="Rrule Botrule " valign="top"> <paragraph> 6</paragraph> </td> </tr> <tr> <td styleCode="Lrule Botrule " valign="top"> <paragraph> Somnolence</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 12</paragraph> </td> <td align="center" styleCode="Rrule Botrule " valign="top"> <paragraph> 5</paragraph> </td> </tr> <tr> <td styleCode="Lrule Botrule " valign="top"> <paragraph> Dizziness</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 9</paragraph> </td> <td align="center" styleCode="Rrule Botrule " valign="top"> <paragraph> 6</paragraph> </td> </tr> <tr> <td styleCode="Lrule Botrule " valign="top"> <paragraph> Tremor</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 9</paragraph> </td> <td align="center" styleCode="Rrule Botrule " valign="top"> <paragraph> 2</paragraph> </td> </tr> <tr> <td styleCode="Lrule Botrule " valign="top"> <paragraph> Libido decreased</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 4</paragraph> </td> <td align="center" styleCode="Rrule Botrule " valign="top"> <paragraph> 1</paragraph> </td> </tr> <tr> <td styleCode="Lrule Botrule " valign="top"> <paragraph> Thinking abnormal</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 2</paragraph> </td> <td align="center" styleCode="Rrule Botrule " valign="top"> <paragraph> 1</paragraph> </td> </tr> <tr> <td styleCode="Lrule Botrule " valign="top"> <paragraph> <content styleCode="bold">Respiratory System</content> </paragraph> </td> <td styleCode="Botrule " valign="top"/> <td styleCode="Rrule Botrule " valign="top"/> </tr> <tr> <td styleCode="Lrule Botrule " valign="top"> <paragraph> Yawn</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 3</paragraph> </td> <td align="center" styleCode="Rrule Botrule " valign="top"> <paragraph> --</paragraph> </td> </tr> <tr> <td styleCode="Lrule Botrule " valign="top"> <paragraph> <content styleCode="bold">Skin and Appendages</content> </paragraph> </td> <td styleCode="Botrule " valign="top"/> <td styleCode="Rrule Botrule " valign="top"/> </tr> <tr> <td styleCode="Lrule Botrule " valign="top"> <paragraph> Sweating</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 7</paragraph> </td> <td align="center" styleCode="Rrule Botrule " valign="top"> <paragraph> 3</paragraph> </td> </tr> <tr> <td styleCode="Lrule Botrule " valign="top"> <paragraph> Rash</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 4</paragraph> </td> <td align="center" styleCode="Rrule Botrule " valign="top"> <paragraph> 3</paragraph> </td> </tr> <tr> <td styleCode="Lrule Botrule " valign="top"> <paragraph> Pruritus</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 3</paragraph> </td> <td align="center" styleCode="Rrule Botrule " valign="top"> <paragraph> 2</paragraph> </td> </tr> <tr> <td styleCode="Lrule Botrule " valign="top"> <paragraph> <content styleCode="bold">Special Senses</content> </paragraph> </td> <td styleCode="Botrule " valign="top"/> <td styleCode="Rrule Botrule " valign="top"/> </tr> <tr> <td styleCode="Botrule Lrule " valign="top"> <paragraph> Abnormal vision</paragraph> </td> <td align="center" styleCode="Botrule " valign="top"> <paragraph> 2</paragraph> </td> <td align="center" styleCode="Rrule Botrule " valign="top"> <paragraph> 1</paragraph> </td> </tr> </tbody> </table>

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.